SMi Release Exclusive Interview Ahead of Paediatric Clinical Trials 2017: Larissa Kerecuk, Rare Disease Lead, the Birmingham Children’s Hospital
The leading industry event "Paediatric Clinical Trials" returns to London on 20th-21st March 2017 for its 11th annual show and is delighted to have Larissa Kerecuk as one of the keynote speakers.
London, United Kingdom, February 01, 2017 --(PR.com)-- In the run up to this year’s event, SMi Group caught up with Larissa to discuss the current landscape of the industry as well as her upcoming presentation entitled ‘Paediatric rare disease research: Challenges & opportunities’. Her presentation will discuss why research into rare diseases is crucial and how care is organised for paediatric patients. She will also explore the challenges and opportunities associated with research into these diseases and why research should be an integral part of care for patients.
“SMi: What do you think the future holds for paediatric clinical trials in the EU and beyond?
LK: In order to ensure that children with rare diseases, which are often life limiting and threatening, obtain the best care they deserve we need to ensure that health care providers, academia and industry throughout the world collaborate to undertake high quality trials which provide meaningful results, and that the results of these trials are rapidly incorporated into patient care. The fantastic improvements seen in cancer treatments have resulted from following this model and there is no reason why it should not work in those with rare diseases as well. The current EU situation is challenging but whenever there are challenges, there are also opportunities to streamline systems that have become counterproductive.”
The full interview is available to access in the event download centre along with several other interviews from this year’s interview series. www.paediatric-trials.co.uk/prcom
The line-up joining Larissa Kerecuk at Paediatric Clinical Trials include handpicked international speakers from EMA, GSK, Insys Therapeutics, Roche, Otsuka and many more as they discuss the topics of regulation, drug development, incentives and recruitment and retention.
For those who are interested in attending register online at the event website www.paediatric-trials.co.uk/prcom
Paediatric Clinical Trials
20-21 March 2017
Copthorne Tara Hotel, London, UK
www.paediatric-trials.co.uk/prcom
Sponsorship enquiries: Contact Alia Malick on: +44 (0) 20 7827 6168 or email amalick@smi-online.co.uk
Group bookings: Contact Ameenah Begum on: +44 (0) 20 7827 6166 or email abegum@smi-online.co.uk
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
“SMi: What do you think the future holds for paediatric clinical trials in the EU and beyond?
LK: In order to ensure that children with rare diseases, which are often life limiting and threatening, obtain the best care they deserve we need to ensure that health care providers, academia and industry throughout the world collaborate to undertake high quality trials which provide meaningful results, and that the results of these trials are rapidly incorporated into patient care. The fantastic improvements seen in cancer treatments have resulted from following this model and there is no reason why it should not work in those with rare diseases as well. The current EU situation is challenging but whenever there are challenges, there are also opportunities to streamline systems that have become counterproductive.”
The full interview is available to access in the event download centre along with several other interviews from this year’s interview series. www.paediatric-trials.co.uk/prcom
The line-up joining Larissa Kerecuk at Paediatric Clinical Trials include handpicked international speakers from EMA, GSK, Insys Therapeutics, Roche, Otsuka and many more as they discuss the topics of regulation, drug development, incentives and recruitment and retention.
For those who are interested in attending register online at the event website www.paediatric-trials.co.uk/prcom
Paediatric Clinical Trials
20-21 March 2017
Copthorne Tara Hotel, London, UK
www.paediatric-trials.co.uk/prcom
Sponsorship enquiries: Contact Alia Malick on: +44 (0) 20 7827 6168 or email amalick@smi-online.co.uk
Group bookings: Contact Ameenah Begum on: +44 (0) 20 7827 6166 or email abegum@smi-online.co.uk
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
Contact
SMi Group
Zoe Gale
+44 20 7827 6166
http://www.paediatric-trials.co.uk/prcom
Zoe Gale
+44 20 7827 6166
http://www.paediatric-trials.co.uk/prcom
Contact
Categories